戴維醫療(300314.SZ)取得3項實用新型專利證書和1項外觀設計專利證書
格隆匯 11 月 23日丨戴維醫療(300314.SZ)公佈,公司於近日取得中華人民共和國國家知識產權局頒發的3項實用新型專利證書和1項外觀設計專利證書,專利名稱分別為:一種支撐腳的固定組件、一種嬰兒電子秤、一種輸氧接口及輸氧裝置、低壓吸引器(S-5)。
上述實用新型專利和外觀設計專利有效期均為10年。以上專利的取得,不會對公司目前生產經營產生重大影響,但有利於公司發揮產品的自主知識產權優勢,對公司開拓市場會產生積極的影響,形成持續創新機制,增強公司的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.